New light commercial vehicle (LCV) registrations fell by 12.1% to 156,048 units in the first half of 2025, according to the ...

Summit Therapeutics jumps 9% as AZN eyes a potential $15 billion licensing deal for its cancer drug, ivonescimab.

Summit Therapeutics (SMMT) stock gains as AstraZeneca (AZN) is said to eye its lung cancer drug ivonescimab, a potential ...

New diesel van registrations shrank by 12.1% to 156,048 units in the first half of 2025, whilst electric van demand rose by ...

Demand for battery-electric vans surged 53 per cent in the UK in the first half of 2025. In June alone, registrations even ...

The new car market recorded its second consecutive month of growth in June, with registrations rising 6.7% year-on-year ...

Summit Therapeutics Inc. (NASDAQ:SMMT) ranks among the 30 stocks expected to beat the market by 20 percentage points this ...

Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...

UK van sales dropped 12.1% in H1 2025, with tax changes and weak economic confidence stalling fleet renewal and slowing the ...

Sales remained below pre-COVID levels, but it was the best June since 2019, the Society of Motor Manufacturers and Traders ...

The UK's new van market shrank every month during the first half of 2025, according to the latest figures. The Society of Motor Manufacturers and Traders (SMMT) said LCV registrations declined by 12.1 ...

As a result, Britain say the strongest June for new car sales since 2019, with 191,316 cars registered, according to the ...